MARC Record from harvard_bibliographic_metadata

LEADER: 02992cam a2200541 a 4500
001 013141718-5
005 20120406192646.0
008 100406s2010 sz a b i000 0 eng
010 $a 2010516097
016 7 $a101535718$2DNLM
016 7 $a015738218$2Uk
020 $a9789241547888 (spiral bound : pbk.)
020 $a924154788X (spiral bound : pbk.)
035 0 $aocn603068849
040 $aNLM$cNLM$dYDXCP$dTPH$dCUX$dHPH$dORU$dGUA$dIXA$dUBY$dNLGGC$dUKMGB$dDLC
042 $anlmcopyc
050 14 $aRM171$b.S384 2010
060 00 $a2010 G-981
060 10 $aWB 356
060 14 $aWB 356$bS433 2010
082 00 $a615.3/9$223
084 $a44.86$2bcl
245 00 $aScreening donated blood for transfusion-transmissible infections :$brecommendations.
260 $aGeneva :$bWorld Health Organization,$cc2010.
300 $a67 p. :$bill. ;$c30 cm.
504 $aIncludes bibliographical references (p. 60-62).
530 $aAlso available via the World Wide Web.
505 0 $aIntroduction -- National blood screening programme for transfusion-transmissible infections -- Screening essays -- Screening for transfusion-transmissible infections -- Blood screening, quarantine and release -- Confirmatory testing and blood donor management -- Quality systems in blood screening.
520 $a"The establishment of systems to ensure that all donated blood is screened for transfusion-transmissible infections is a core component of every national blood programme. Globally, however, there are significant variations in the extent to which donated blood is screened, the screening strategies adopted and the overall quality and effectiveness of the blood screening process. As a result, in many countries the recipients of blood and blood products remain at unacceptable risk of acquiring life-threatening infections that could easily be prevented. These recommendations are designed to support countries in establishing effective national programmes to ensure 100% quality-assured screening of donated blood for transfusion-transmissible infections. In countries where systems are not yet fully in place, the recommendations will be helpful in instituting a step-wise process to implement them."--Publisher's description.
650 17 $aKwaliteitszorg.$2gtt
650 17 $aScreening.$2gtt
650 17 $aDonors.$2gtt
650 17 $aBesmetting.$2gtt
650 17 $aInfecties.$2gtt
650 17 $aBijwerkingen.$2gtt
650 17 $aStandaardisatie.$2gtt
650 17 $aBloedtransfusie.$2gtt
650 12 $aBlood Transfusion$xadverse effects.
650 22 $aBlood Transfusion$xstandards.
650 22 $aDisease Transmission, Infectious$xprevention & control.
650 22 $aDonor Selection$xstandards.
650 22 $aNational Health Programs$xstandards.
650 0 $aBlood$xTransfusion$xComplications.
650 0 $aBlood$xTransfusion$xSafety measures.
650 0 $aBlood donors$xDiseases.
710 2 $aWorld Health Organization.
988 $a20120329
906 $0OCLC